ATMP Safety Testing Day Registrations

ATMP Safety Testing Day – CCRM Nordic & bioMérieux

Thu 25 September 2025 from 09:00 to 16:00

Join us for a focused day on safety testing in ATMP development.This event is designed for professionals working in advanced therapy medicinal products (ATMPs) who want to deepen their understanding of safety testing strategies and regulatory expectations.

Save the Date: Thursday, 25 September 2025

Location: GoCo Health Innovation City, Sweden

Theme: Selecting Safety Tests to Support Your ATMP Development Pathway

Focus Areas: Sterility • Mycoplasma • Endotoxin

Topics Include:

• Safety testing in ATMPs
• Regulatory aspects and compliance
• Method selection and validation
• Practical challenges and solutions
• Hands-on demos and workshops

Why Attend? Gain practical insights, connect with experts, and explore the latest in safety testing technologies that support your ATMP pipeline from concept to clinic.

Ticket prices: 200 SEK per ticket, includes: full day of activities, lunch and coffee breaks. Link for payment will be forwarded to you when your registration is confirmed.

Register here: HOME – ATMP Safety Testing Day – CCRM Nordic & bioMérieux

For more information, check out: ATMP Safety Testing Day Agenda

About CCRM Nordic:

CCRM Nordic is a leading organization dedicated to advancing research, development, and commercialization of advanced therapy medicinal products (ATMPs). With a focus on innovation and collaboration, CCRM Nordic strives to accelerate the translation of scientific discoveries into tangible therapies that address unmet medical needs.

Visit ccrmnordic.se

About CCRM:

CCRM is a global, public-private partnership headquartered in Canada, established with seed funding provided by the Government of Canada, the Province of Ontario, and leading academic and industry partners. CCRM supports the development of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy. A network of researchers, leading companies, investors and entrepreneurs, CCRM accelerates the translation of scientific discovery into new companies and marketable products for patients, with specialized teams, dedicated funding, and unique infrastructure. In 2022, CCRM established OmniaBio Inc., a pre-clinical to commercial-stage CDMO for manufacturing gene-modified cells and viral vectors for cell and gene therapies. CCRM is hosted by the University of Toronto. Visit at ccrm.ca